Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Regulating protein degradation by ubiquitination

A M Weissman¹

¹Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1152, USA. amw@nih.gov

Immunology Today

|April 1, 1997

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inhibiting Hdm2 and ubiquitin-activating enzyme: targeting the ubiquitin conjugating system in cancer.

Ernst Schering Foundation symposium proceedings·2009

Same author

RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene.

Oncogene·2006

Same author

Assay for ubiquitin ligase activity: high-throughput screen for inhibitors of HDM2.

Journal of biomolecular screening·2005

Same author

A field guide to ubiquitylation.

Cellular and molecular life sciences : CMLS·2004

Same author

Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity.

FEBS letters·2004

Same author

The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.

Proceedings of the National Academy of Sciences of the United States of America·2001